EUVIMEDEUVIMED entdecken
Open Access

Differential Modulation of Galectin-3 by Tamoxifen and Progesterone Receptor Modulators: An In Vitro and In Silico Study

Adamantia Kontogeorgi, Ioannis Boutas, George Agrogiannis, Dimitrios Kalaitzis, Tatiana S Driva, Emmanouil Zoumakis, Sophia N Kalantaridou, Antonios Makrigiannakis

In Vivo · 2026-11 · 40 (6) · 3429-3444

DOI: 10.21873/invivo.14487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, online erschienen am 29.10.2026. Verfasst von Adamantia Kontogeorgi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, University of Crete, Heraklion, Greece; Adamantia.kondogewrgi@gmail.com. Hauptthemen laut MEDLINE: Tamoxifen, Receptors, Progesterone, Galectin 3. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TamoxifenReceptors, ProgesteroneGalectin 3HumansFemaleSignal TransductionNorpregnadienesMifepristoneCell Line, TumorGalectinsEndometriumEndometrial NeoplasmsBlood Proteins

Stichwörter der Autor:innen

Galectin-3antiprogestinsendocrine therapyendometrial safety

Substanzen

TamoxifenReceptors, ProgesteroneGalectin 3NorpregnadienesMifepristoneGalectinsulipristal acetateBlood ProteinsLGALS3 protein, human

Autor:innen und Institutionen

  • Medical School, University of Crete, Heraklion, Greece; Adamantia.kondogewrgi@gmail.com.
  • Department of Obstetrics and Gynecology, University of Crete, Heraklion, Greece.
  • 2nd Department of Propedeutic Surgery, "Laiko" General Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
  • Independent Authority of Public Revenue, Athens, Greece.
  • 1st Department of Pathology, General Hospital of Athens "Laiko", Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • 1st Department of Pediatrics, University of Athens Medical School, Agia Sofia Hospital, Athens, Greece.

Zitieren

APA

Kontogeorgi, A., Boutas, I., Agrogiannis, G., Kalaitzis, D., Driva, T. S., Zoumakis, E., Kalantaridou, S. N., & Makrigiannakis, A. (2026). Differential Modulation of Galectin-3 by Tamoxifen and Progesterone Receptor Modulators: An In Vitro and In Silico Study. In Vivo, 40(6), 3429-3444. https://doi.org/10.21873/invivo.14487

Vancouver

Kontogeorgi A, Boutas I, Agrogiannis G, Kalaitzis D, Driva TS, Zoumakis E, et al. Differential Modulation of Galectin-3 by Tamoxifen and Progesterone Receptor Modulators: An In Vitro and In Silico Study. In Vivo. 2026;40(6):3429-3444. doi:10.21873/invivo.14487

BibTeX
@article{Kontogeorgi2026,
  author = {Kontogeorgi, Adamantia and Boutas, Ioannis and Agrogiannis, George and Kalaitzis, Dimitrios and Driva, Tatiana S and Zoumakis, Emmanouil and Kalantaridou, Sophia N and Makrigiannakis, Antonios},
  title = {Differential Modulation of Galectin-3 by Tamoxifen and Progesterone Receptor Modulators: An In Vitro and In Silico Study},
  journal = {In Vivo},
  year = {2026},
  volume = {40},
  number = {6},
  pages = {3429--3444},
  doi = {10.21873/invivo.14487}
}
Kostenlos starten →